Syra Health Corp.
SYRA
$0.0502
-$0.005-9.06%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -10.94% | 14.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.94% | 14.40% | |||
| Cost of Revenue | -2.12% | -2.14% | |||
| Gross Profit | -31.86% | 90.94% | |||
| SG&A Expenses | -7.90% | -28.25% | |||
| Depreciation & Amortization | -71.37% | 46.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.48% | -20.17% | |||
| Operating Income | -16.97% | 69.15% | |||
| Income Before Tax | -20.81% | 69.97% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -20.81% | 69.97% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.81% | 69.97% | |||
| EBIT | -16.97% | 69.15% | |||
| EBITDA | -22.56% | 70.62% | |||
| EPS Basic | 10.78% | 72.70% | |||
| Normalized Basic EPS | 10.86% | 72.72% | |||
| EPS Diluted | 10.78% | 72.70% | |||
| Normalized Diluted EPS | 10.86% | 72.72% | |||
| Average Basic Shares Outstanding | 35.43% | 10.03% | |||
| Average Diluted Shares Outstanding | 35.43% | 10.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||